Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 31, 2019

SELL
$59.47 - $93.1 $8.43 Million - $13.2 Million
-141,700 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$105.8 - $150.94 $5.26 Million - $7.5 Million
49,700 Added 54.02%
141,700 $24.2 Million
Q4 2017

Feb 13, 2018

BUY
$81.25 - $130.7 $7.48 Million - $12 Million
92,000
92,000 $16.4 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $598M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Menora Mivtachim Holdings Ltd. Portfolio

Follow Menora Mivtachim Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.